The Prevalence of Fabry Disease in Patients with Chronic Kidney Disease in Turkey: The TURKFAB Study.

Kultigin Turkmen,Aydın Güçlü,Garip Sahin,Ismail Kocyigit,Levent Demirtas,Fatih Mehmet Erdur,Sengul E,Oktay Özkan,Habib Emre,Faruk Turgut,Hilmi Umut Unal,Murat Karaman,Cengiz Açıkel,Hasan Esen,Ebru Balli,Gulfidan Bitirgen,Halil Zeki Tonbul,Mahmut Ilker Yilmaz,Alberto Ortiz

The Prevalence of Fabry Disease in Patients with Chronic Kidney Disease in Turkey: The TURKFAB Study.

2016

Kultigin Turkmen
Aydın Güçlü
Garip Sahin
Ismail Kocyigit
Levent Demirtas
Fatih Mehmet Erdur
Sengul E
Oktay Özkan
Habib Emre
Faruk Turgut
Hilmi Umut Unal
Murat Karaman
Cengiz Açıkel
Hasan Esen
Ebru Balli
Gulfidan Bitirgen
Halil Zeki Tonbul
Mahmut Ilker Yilmaz
Alberto Ortiz

Background/Aims: Fabry disease is a treatable cause of chronic kidney disease (CKD) characterized by a genetic deficiency of α-galactosidase A. European Renal Bes

Keywords:

Endocrinology
Internal medicine
Fabry disease
Kidney disease
Diabetes mellitus
Medicine
Pathology
Alpha-galactosidase
in patient
mass screening
Prospective cohort study
DNA Mutational Analysis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations